Stay updated on DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.

Latest updates to the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision identifier was updated from v3.6.5 to v3.6.6, indicating a new build or maintenance update rather than visible content changes.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA site revision update from v3.6.4 to v3.6.5, indicating a new build of the page. The update reflects a software revision rather than a change to the study content or visible information.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision bumped from v3.6.3 to v3.6.4, indicating a minor update to the page's software/template.SummaryDifference0.0%

- Check70 days agoChange DetectedThe revision tag was updated to v3.6.3 from v3.6.2, reflecting a small maintenance update.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now displays a newer revision tag (v3.6.2) replacing the previous v3.6.0. This indicates a minor software update applied to the page.SummaryDifference0.0%

- Check91 days agoChange DetectedThe study page now indicates that enrollment has closed, and additional help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added.SummaryDifference0.4%

Stay in the know with updates to DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.